Bio-pharma: A financialized business model

Rebuilding Big Pharma ’ s Business Model

Four inter-related building blocks can provide the new foundation: focusing R&D efforts and commercial capabilities; making use of product and capability partnerships; providing customer solutions (not just “therapeutics”), and creating a business unit based organization model instead of a functional one. Companies need to find a combination of these building blocks that makes best use of their...

A Business Model to Detect Disease Outbreaks

Introduction: Every year several disease outbreaks, such as influenza-like illnesses (ILI) and other contagious illnesses, impose various costs to public and non-government agencies. Most of these expenses are due to not being ready to handle such disease outbreaks. An appropriate preparation will reduce the expenses. A system that is able to recognize these outbreaks can earn ...

International Journal of Pharma and Bio Sciences Mycoremediatio of Moocrotophos

The persistence of Monocrotophos (MCP) an extensively used Organophosphorous pesticide in environment and its toxic effect on biota necessitate its removal. A soil fungus capable of utilizing or breaking down MCP was isolated from a site contaminated by the same pesticide. The fungus Aspergillus sp. was inoculated into the medium with 0.5% MCP. After 8 days of incubation the biodegradation of M...

University Business Model Framework

The purpose of this study is to provide a framework for the university business model as a solution for universities to cooperate with businesses. The method of the present study is a qualitative case study and the research method of document analysis, focal groups have been used to collect data. In the documentation section, 60 documents related to academic business models were selected and an...

Good pharma? Bad pharma? Better pharma.